The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 22, 2022

Filed:

Jun. 17, 2019
Applicants:

The United States of America, As Represented BY the Secretary, Dept. of Health and Human Services, Bethesda, MD (US);

Washington University, St. Louis, MO (US);

Inventors:

Jeffrey S. Isenberg, Mt. Lebanon, PA (US);

David D. Roberts, Bethesda, MD (US);

William A. Frazier, Rock Hill, MO (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/18 (2006.01); A61K 48/00 (2006.01); G01N 33/68 (2006.01); C07K 7/06 (2006.01); C07K 9/00 (2006.01); C07K 14/475 (2006.01); C07K 14/78 (2006.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01); B01J 21/06 (2006.01); B01J 21/12 (2006.01); B01J 23/00 (2006.01); B01J 23/30 (2006.01); B01J 27/188 (2006.01); B01J 37/02 (2006.01); C07C 45/00 (2006.01); C07C 45/52 (2006.01); C07C 51/235 (2006.01); C07C 51/25 (2006.01); C07C 253/26 (2006.01); A61P 7/04 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/18 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); A61K 48/00 (2013.01); B01J 21/063 (2013.01); B01J 21/12 (2013.01); B01J 23/002 (2013.01); B01J 23/30 (2013.01); B01J 27/188 (2013.01); B01J 37/0205 (2013.01); C07C 45/002 (2013.01); C07C 45/52 (2013.01); C07C 51/235 (2013.01); C07C 51/252 (2013.01); C07C 253/26 (2013.01); C07K 7/06 (2013.01); C07K 9/001 (2013.01); C07K 14/475 (2013.01); C07K 14/78 (2013.01); G01N 33/6887 (2013.01); G01N 33/6893 (2013.01); A61K 2039/505 (2013.01); A61P 7/04 (2018.01); B01J 2523/00 (2013.01); C07K 2317/76 (2013.01); G01N 2333/705 (2013.01);
Abstract

Provided herein are compositions for preventing, ameliorating, and/or reducing tissue ischemia and/or tissue damage due to ischemia, increasing blood vessel diameter, blood flow and tissue perfusion in the presence of vascular disease including peripheral vascular disease, atherosclerotic vascular disease, coronary artery disease, stroke and influencing other conditions, by suppressing CD47 and/or blocking TSP1 and/or CD47 activity or interaction. Influencing the interaction of CD47-TSP1 in blood vessels allows for control of blood vessel diameter and blood flow, and permits modification of blood pressure and cardiac function. Under conditions of decreased blood flow, for instance through injury or atherosclerosis, blocking TSP1-CD47 interaction allows blood vessels to dilate and increases blood flow, tissue perfusion and tissue survival.


Find Patent Forward Citations

Loading…